NCJ Number
244263
Date Published
October 2007
Length
0 pages
Annotation
This Web page contains a summary of the discussion resulting from the Panel on Medication-Assisted Treatment for Heroin and Other Opioid Abusing Offenders held in Washington, DC, on October 3, 2007.
Abstract
This Web page located on the National Institute of Justice's Web site, contains a summary of the panel discussion on medication-assisted treatment for heroin and other opioid abusing offenders held in Washington, DC, on October 3, 2007. The primary objective of the meeting was to examine the use of opioids and treatment options for offenders who are incarcerated or under supervision in the community. Previous research has found that while counseling and other non-medication treatment therapies can be successful, the use of medications such as methadone and buprenorphine can also improve outcomes for offenders. Several issues that could affect the outcomes for offenders were raised during the discussion. These included the treatment philosophy of complete abstinence (clean and sober), the appropriateness of short-term (buprenorphine) vs. long-term (methadone) regimens, heroin (including injection drug) vs. other opioid (prescription drug) abusers, and nonclinical problems of compliance and improper use (boosting with alcohol and other drugs).
Date Published: October 1, 2007
Downloads
Similar Publications
- In Pursuit of Fairness: A Research Note on Gender Responsivity and Racial Bias in Criminal Justice Actuarial Risk Assessments
- "I Feel Like I'm Always on Edge": Perceptions of Parole Supervision by Parolees with Substance Use Disorders
- The Impact of Individualized Focused Deterrence on Criminal and Prosocial Outcomes